94 related articles for article (PubMed ID: 1693863)
21. The management of patients with clinical stage I nonseminomatous testicular tumors and persistently elevated serologic markers.
Saxman SB; Nichols CR; Foster RS; Messemer JE; Donohue JP; Einhorn LH
J Urol; 1996 Feb; 155(2):587-9. PubMed ID: 8558665
[TBL] [Abstract][Full Text] [Related]
22. [Biological markers and germinal tumors of the testis. Value and limitations of the assay of chorionic gonadotrophin hormone and alpha-fetoprotein].
Bassoulet J; Pabot du Chatelard P; Ricordel I; Auberget JL; Guillemot MC; Merrer J; Timbal Y
J Urol (Paris); 1988; 94(8):393-6. PubMed ID: 2467947
[TBL] [Abstract][Full Text] [Related]
23. Nonseminomatous germ cell testicular tumors clinical stage I: differentiated therapeutic approach in comparison with therapeutic approach using surveillance strategy only.
Ondrus D; Ondrusova M; Hornak M; Matoska J
Neoplasma; 2007; 54(5):437-42. PubMed ID: 17688374
[TBL] [Abstract][Full Text] [Related]
24. Testicular cancer in Luxembourg: incidence and outcome in relation to the different histo-pathological types (1980-2004).
Scheiden R; Hein T; Wagener C; Kieffer N; Lamy S; Capesius C
Bull Soc Sci Med Grand Duche Luxemb; 2008; (4):521-39. PubMed ID: 19024372
[TBL] [Abstract][Full Text] [Related]
25. The case for observation of patients with clinical stage I nonseminomatous germ cell testicular tumors.
Swanson DA
Semin Urol; 1993 May; 11(2):92-8. PubMed ID: 7689741
[No Abstract] [Full Text] [Related]
26. [Sterility and tumors of the testis. Study of late exocrine and endocrine functions in stage I or IIA tumors].
Bouchot O; Plougastel ML; Karam G; Bochereau G; Auvigne J
J Urol (Paris); 1989; 95(6):367-71. PubMed ID: 2478640
[TBL] [Abstract][Full Text] [Related]
27. [Biological markers in testicular cancer].
Glait HM; Carugati A; Scorticati C; Koss A; Bellora O; Mickiewicz E; Arturi J; Olivari AJ
Medicina (B Aires); 1982; 42(5):488-94. PubMed ID: 6188940
[No Abstract] [Full Text] [Related]
28. Compliance and outcome of patients with stage 1 non-seminomatous germ cell tumors (NSGCT) managed with surveillance programs in seven Canadian centres.
Ernst DS; Brasher P; Venner PM; Czaykowski P; Moore MJ; Reyno L; Winquist E; Segal R; Hao D
Can J Urol; 2005 Apr; 12(2):2575-80. PubMed ID: 15877938
[TBL] [Abstract][Full Text] [Related]
29. [Treatment of 95 non-seminomatous germinal tumors of the testis].
El Hafed A; Metz R; Dartois D
Acta Chir Belg; 1980; 79(3):195-203. PubMed ID: 7190760
[TBL] [Abstract][Full Text] [Related]
30. [Seminoma of testis. Analysis of failures and development of therapeutic strategies. Apropos of a Lyons series of 117 cases].
Gérard JP; Chassard JL; Mère P; Biron P; Dutou L; Papillon J
J Urol (Paris); 1986; 92(8):531-7. PubMed ID: 3805747
[TBL] [Abstract][Full Text] [Related]
31. [A clinico-statistical study of testicular tumors--a reevaluation of 90 cases at the Nagasaki University Hospital and affiliated hospitals].
Nomata K; Nisimura N; Taniguchi K; Kanetake H; Shindo K; Saito Y; Shimada O; Tsuda N; Tasaki T; Harra T
Gan No Rinsho; 1988 Aug; 34(9):1115-20. PubMed ID: 2845172
[TBL] [Abstract][Full Text] [Related]
32. Histopathologic classification and natural history of malignant testis tumors in Norway, 1959-1963.
Miller A; Seljelik R
Cancer; 1971 Oct; 28(4):1054-62. PubMed ID: 4398758
[No Abstract] [Full Text] [Related]
33. Subtype-specific incidence of testicular cancer in Germany: a pooled analysis of nine population-based cancer registries.
Stang A; Rusner C; Eisinger B; Stegmaier C; Kaatsch P
Int J Androl; 2009 Aug; 32(4):306-16. PubMed ID: 18179558
[TBL] [Abstract][Full Text] [Related]
34. The role of alpha-fetoprotein and human chorionic gonadotropin in seminoma.
Javadpour N; McIntire KR; Waldmann TA; Bergman SM
J Urol; 1978 Dec; 120(6):687-90. PubMed ID: 83391
[No Abstract] [Full Text] [Related]
35. Biochemical markers for testicular germ-cell tumors in relation to histology and stage: some experiences from the Danish testicular cancer (DATECA) Study from 1976 through 1981.
Nørgaard-Pedersen B; Schultz H; Arends J; Brincker H; Jacobsen GK; Lindeløv B; Rørth M; Svennekjaer IL
Ann N Y Acad Sci; 1983; 417():390-9. PubMed ID: 6200044
[TBL] [Abstract][Full Text] [Related]
36. Clinical characteristics and oncological outcomes of testicular cancer patients registered in 2005 and 2008: the first large-scale study from the Cancer Registration Committee of the Japanese Urological Association.
Miki T; Kamoi K; Fujimoto H; Kanayama HO; Ohyama C; Suzuki K; Nishiyama H; Eto M; Naito S; Fukumori T; Kubota Y; Takahashi S; Mikami K; Homma Y
Int J Urol; 2014 Aug; 21(8):S1-6. PubMed ID: 24725194
[TBL] [Abstract][Full Text] [Related]
37. Lactic dehydrogenase in the monitoring and prognosis of testicular cancer.
Lippert MC; Javadpour N
Cancer; 1981 Nov; 48(10):2274-8. PubMed ID: 6170417
[TBL] [Abstract][Full Text] [Related]
38. [Treatment of stage I, II testicular tumor based on tumor markers].
Kamidono S; Arakawa S; Hamami G; Umezu K; Fujii A; Ishigami J
Nihon Hinyokika Gakkai Zasshi; 1983 Aug; 74(8):1383-93. PubMed ID: 6202917
[No Abstract] [Full Text] [Related]
39. [Epidemiology of tumors of the testis].
Mandron E; Schill H
Arch Anat Cytol Pathol; 1992; 40(4):190-4. PubMed ID: 1294047
[TBL] [Abstract][Full Text] [Related]
40. The value of serum tumor markers in the staging and prognosis of germ cell tumors of the testis.
Scardino PT; Cox HD; Waldmann TA; Mcintire KR; Mittemeyer B; Javadpour N
J Urol; 1977 Dec; 118(6):994-9. PubMed ID: 72833
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
